OPRX (OptimizeRx Inc.) יחס שווי פעילות לרווח לפני ריבית, מסים ופחת
The daily price action for OptimizeRx Corporation (OPRX) shown on this chart reflects an EV/EBITDA of 11.27. The company is expanding digital communication channels between healthcare providers and patients by implementing AI tools. Regular software payments ensure a steady cash flow, maintaining high operational momentum. Despite a moderate dependence on economic cycles, the overall modernization of the industry guarantees sustainable demand for the company's services.
פילוחים אנליטיים של חברת OptimizeRx Corporation
The stable cash flow from IT solution subscriptions at OptimizeRx Corporation (OPRX) makes the company's EV/EBITDA ratio a key valuation tool in a historical context. This multiple compares the total enterprise value, including net debt, with its operating profit before depreciation and taxes. Such a mechanism eliminates the impact of accounting policies and debt loads on core efficiency. This helps investors determine the fair value of the asset relative to its actual ability to act as a cash generator.
